Valuation: Amarin Corporation plc

Market Cap 34Cr 30Cr 28Cr 26Cr 49Cr 3.27TCr 49Cr 331.07Cr 128.7Cr 1.61TCr 128.85Cr 126.08Cr 5.54TCr P/E 2026 *
-468x
P/E 2027 * 298x
Enterprise Value 17Cr 15Cr 14Cr 13Cr 24Cr 1.61TCr 24Cr 163.38Cr 64Cr 792.83Cr 64Cr 62Cr 2.73TCr EV / Sales 2026 *
0.93x
EV / Sales 2027 * 0.81x
Free-Float
89.38%
Yield 2026 *
-
Yield 2027 * -
1 day-0.61%
1 week+2.89%
Current month+2.70%
1 month+18.62%
3 months+11.06%
6 months+19.31%
Current year+17.31%
1 week 15.5
Extreme 15.5001
16.79
1 month 13.92
Extreme 13.92
17.25
Current year 12.96
Extreme 12.96
17.31
1 year 12.96
Extreme 12.96
20.9
3 years 7.08
Extreme 7.08
29.7
5 years 7.08
Extreme 7.08
119.4
10 years 7.08
Extreme 7.08
522.4
Manager TitleAgeSince
Chief Executive Officer 63 04/06/2024
Director of Finance/CFO 42 23/10/2024
Compliance Officer 56 15/11/2023
Director TitleAgeSince
Director/Board Member 63 04/06/2024
Director/Board Member 43 28/02/2023
Director/Board Member 67 28/02/2023
Date Insider Type Main position Quantity % Market Cap.
26/06Fiscal year

Chief Executive Officer

15,697 0.0038%
18/04Fiscal year

Chairman

2,079 0.0005%
18/04Fiscal year

Director

2,079 0.0005%
Change 5-day change 1-year change 3-year change Capi.($)
-0.61%+2.89%-2.15%-30.04% 34Cr
+0.68%+5.92%+77.86%+139.22% 5.91TCr
+2.32%+5.03%+75.26%+91.40% 5.52TCr
+3.86%+6.93%-11.32%-9.53% 2.47TCr
+4.30%+7.95%+14.11%+437.83% 2.42TCr
+4.74%+13.68%+43.36%-4.67% 1.97TCr
-0.29%+9.78%+43.90%-28.41% 1.76TCr
0.00%+20.78%+186.15%+361.42% 1.62TCr
+6.72%+19.38%+37.85% - 1.48TCr
+3.50%+1.97%+21.02%+191.95% 1.4TCr
Average +2.52%+7.72%+48.60%+127.68% 2.46TCr
Weighted average by Cap. +2.46%+6.47%+58.24%+136.73%

Financials

2026 *2027 *
Net sales 18Cr 16Cr 15Cr 14Cr 26Cr 1.74TCr 26Cr 175.77Cr 68Cr 852.97Cr 68Cr 67Cr 2.94TCr 19Cr 17Cr 15Cr 14Cr 27Cr 1.84TCr 28Cr 186.06Cr 72Cr 902.88Cr 72Cr 71Cr 3.11TCr
Net income -1.5Cr -1.31Cr -1.21Cr -1.12Cr -2.13Cr -143.04Cr -2.17Cr -14Cr -5.63Cr -70Cr -5.64Cr -5.52Cr -242.29Cr 2.21Cr 1.93Cr 1.78Cr 1.66Cr 3.14Cr 210.72Cr 3.19Cr 21Cr 8.3Cr 103.58Cr 8.31Cr 8.13Cr 356.93Cr
Net Debt -17Cr -15Cr -14Cr -13Cr -25Cr -1.66TCr -25Cr -167.69Cr -65Cr -813.75Cr -65Cr -64Cr -2.8TCr -19Cr -16Cr -15Cr -14Cr -27Cr -1.79TCr -27Cr -180.83Cr -70Cr -877.48Cr -70Cr -69Cr -3.02TCr
Logo Amarin Corporation plc
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
Employees
80
Date Price Change Volume
02/26/02 $16.37 -0.61% 91,697
01/26/01 $16.47 +3.32% 72,318
30/26/30 $15.94 +0.13% 83,108
29/26/29 $15.92 +0.06% 1,05,805
26/26/26 $15.91 -2.69% 75,133
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
16.37USD
Average target price
12.50USD
Spread / Average Target
-23.64%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMRN Stock